Understanding how epigenetic changes affect neuroendocrine cancers
Administrative Core
This study is all about helping researchers work together better to understand how certain cancers, like prostate and lung cancer, are affected by changes in our genes, which could lead to better treatments for patients like you.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11016328 on NIH RePORTER |
What this research studies
This research focuses on the administrative support for a program investigating neuroendocrine cancers, which include cancers from prostate, lung, intestine, and skin tissues. The Administrative Core will ensure effective collaboration among various projects and facilitate communication among researchers. By managing logistics, financial accounting, and coordinating meetings, the Core aims to enhance the overall understanding of how epigenetic mechanisms influence these cancers. Patients may benefit indirectly through improved research outcomes and advancements in treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with neuroendocrine cancers, particularly those affecting the prostate, lung, intestine, or skin.
Not a fit: Patients with non-neuroendocrine cancers or those not affected by epigenetic changes may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for patients with neuroendocrine cancers.
How similar studies have performed: Previous research has shown promising results in understanding epigenetic changes in various cancers, indicating that this approach has potential for success.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Decaprio, James a. — Dana-Farber Cancer Inst
- Study coordinator: Decaprio, James a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.